作为急性心力衰竭患者心力衰竭事件预测器的入院低血症
Yuke Sarastri1,2, Juang Idaman Zebua2, Puja Nastia Lubis2
1Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
ESC heart failure
|July 31, 2023
概括
患有心力衰竭的患者的血清水平低 (低血血) 预示着更糟糕的结果. 这种情况与死亡率增加和在六个月内重新入院有关.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 心力衰竭是印度尼西亚的主要心血管挑战.
- 低血清 (低血清) 是心力衰竭患者的常见并发症.
- 心力衰竭中低血的预后意义需要进一步定义.
研究的目的:
- 调查急性心力衰竭患者入院血清水平的预后价值.
- 确定低血与临床结果之间的关联,包括死亡率和住院治疗.
主要方法:
- 研究了134名急性心力衰竭患者的队列.
- 在入院时测量了血清水平.
- 对患者进行了六个月的随访,以评估复合临床结果 (全因死亡率和住院治疗).
主要成果:
- 134名患者中有84名 (62.7%) 呈现低血 (血清<135mEq/L).
- 低血与复合结果的更高风险显著相关 (OR,5.9;95% CI,2.8-12.0).
- 低血症独立地预测了死亡率 (OR,3.1;95% CI,1.4-6.8) 和再住院 (OR,5.3;95% CI,2.4-11.7).
结论:
- 入院低血是心力衰竭患者6个月死亡率和再住院的重要预测因素.
- 这些发现强调了监测心力衰竭中的血清水平的临床重要性.
- 进一步的研究是有必要的,以探索纠正低血症在这个人群中的治疗益处.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.9K
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
665
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Heart Failure VII: Nursing Interventions
96
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
96
Heart Failure Drugs: Diuretics
420
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
420
Heart Failure I: Introduction
16
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
16
Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
